Paper36903259
Brief History, Preparation Method, and Biological Application of Mesoporous Silica Molecular Sieves: A Narrative Review.
Li Q and 1 other. Molecules, 2023. Cited by 26 papers, by iCite.
Cite this record
ConductScience Library. Brief History, Preparation Method, and Biological Application of Mesoporous Silica Molecular Sieves: A Narrative Review. Papers, record 36903259. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36903259
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Brief History, Preparation Method, and Biological Application of Mesoporous Silica Molecular Sieves: A Narrative Review.
- PubMed
Topics5
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Drug Delivery Systems | Major topic |
| Nanospheres | Major topic |
| Humans | |
| Silicon Dioxide | |
| Porosity |
Source PubMed
Grants4
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| GJJ218108 | Science and Technology Research Project of Jiangxi Provincial Department of Education | PubMed | ||
| 21701092 | National Natural Science Foundation of China | PubMed | ||
| LY21B010002 | Natural Science Foundation of Zhejiang Province | PubMed | ||
| 2021J105, 2022J104 | Natural Science Foundation of Ningbo | PubMed |
Source PubMed
References65
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28737672 | Mesoporous Silica Nanoparticles as Drug Delivery Vehicles in Cancer. | Nanomaterials (Basel) | 2017 | https://conductscience.org/library/papers/28737672 | PubMed |
| 2 | 27429897 | Biodegradable and Renal Clearable Inorganic Nanoparticles. | Adv Sci (Weinh) | 2016 | https://conductscience.org/library/papers/27429897 | PubMed |
| 3 | 32625658 | Re-evaluation of silicon dioxide (E 551) as a food additive. | EFSA J | 2018 | https://conductscience.org/library/papers/32625658 | PubMed |
| 4 | 33463299 | Ultrasound Responsive Magnetic Mesoporous Silica Nanoparticle-Loaded Microbubbles for Efficient Gene Delivery. | ACS Biomater Sci Eng | 2020 | https://conductscience.org/library/papers/33463299 | PubMed |
| 5 | 27877767 | Quick high-temperature hydrothermal synthesis of mesoporous materials with 3D cubic structure for the adsorption of lysozyme. | Sci Technol Adv Mater | 2015 | https://conductscience.org/library/papers/27877767 | PubMed |
| 6 | 30978917 | Conventional and Microwave Hydrothermal Synthesis and Application of Functional Materials: A Review. | Materials (Basel) | 2019 | https://conductscience.org/library/papers/30978917 | PubMed |
| 7 | 30551360 | Mesoporous silica nanoparticles for therapeutic/diagnostic applications. | Biomed Pharmacother | 2019 | https://conductscience.org/library/papers/30551360 | PubMed |
| 8 | 32915551 | Hierarchically Structured Zeolites: From Design to Application. | Chem Rev | 2020 | https://conductscience.org/library/papers/32915551 | PubMed |
| 9 | 27017579 | Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery. | Biomaterials | 2016 | https://conductscience.org/library/papers/27017579 | PubMed |
| 10 | 20957080 | Sol gel-derived SBA-16 mesoporous material. | Int J Mol Sci | 2010 | https://conductscience.org/library/papers/20957080 | PubMed |
| 11 | 33797131 | Nanocatalytic Innate Immunity Activation by Mitochondrial DNA Oxidative Damage for Tumor-Specific Therapy. | Adv Mater | 2021 | https://conductscience.org/library/papers/33797131 | PubMed |
| 12 | 26258053 | Mesoporous silica nanoparticles in target drug delivery system: A review. | Int J Pharm Investig | 2015 | https://conductscience.org/library/papers/26258053 | PubMed |
| 13 | 30789700 | Core-Shell Magnetic Mesoporous Silica Microspheres with Large Mesopores for Enzyme Immobilization in Biocatalysis. | ACS Appl Mater Interfaces | 2019 | https://conductscience.org/library/papers/30789700 | PubMed |
| 14 | 33857372 | Magnetism, Ultrasound, and Light-Stimulated Mesoporous Silica Nanocarriers for Theranostics and Beyond. | J Am Chem Soc | 2021 | https://conductscience.org/library/papers/33857372 | PubMed |
| 15 | 12916034 | High-temperature generalized synthesis of stable ordered mesoporous silica-based materials by using fluorocarbon-hydrocarbon surfactant mixtures. | Angew Chem Int Ed Engl | 2003 | https://conductscience.org/library/papers/12916034 | PubMed |
| 16 | 23249963 | An overview of the synthesis of ordered mesoporous materials. | Chem Commun (Camb) | 2013 | https://conductscience.org/library/papers/23249963 | PubMed |
| 17 | 34772454 | Advances in the development of hemostatic biomaterials for medical application. | Biomater Res | 2021 | https://conductscience.org/library/papers/34772454 | PubMed |
| 18 | 33812586 | Rapid hemostasis accompanied by antibacterial action of calcium crosslinking tannic acid-coated mesoporous silica/silver Janus nanoparticles. | Mater Sci Eng C Mater Biol Appl | 2021 | https://conductscience.org/library/papers/33812586 | PubMed |
| 19 | 31892096 | Multifunctional mesoporous silica nanoplatform based on silicon nanoparticles for targeted two-photon-excited fluorescence imaging-guided chemo/photodynamic synergetic therapy in vitro. | Talanta | 2020 | https://conductscience.org/library/papers/31892096 | PubMed |
| 20 | 26061298 | Nanocarriers for cancer-targeted drug delivery. | J Drug Target | 2016 | https://conductscience.org/library/papers/26061298 | PubMed |
Cited by14
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42453132 | Toxicity of orally administrated biodegradable mesoporous silica nanoparticles in mice. | Front Bioeng Biotechnol | 2026 | https://conductscience.org/library/papers/42453132 | PubMed |
| 42195941 | Bleaching Performance and Mechanism of Al-MCM-41 Tuned by Si/Al in Rapeseed Oil. | Foods | 2026 | https://conductscience.org/library/papers/42195941 | PubMed |
| 41695292 | Mesoporous silica nanoparticles--based functional platforms for breast cancer therapy: technological advancements. | Front Chem | 2025 | https://conductscience.org/library/papers/41695292 | PubMed |
| 41149290 | Design, Synthesis and Sensing Application of Novel Dual Lanthanide Doped Core-Shell Fluorescent Silica-Based Nanoparticles. | Biosensors (Basel) | 2025 | https://conductscience.org/library/papers/41149290 | PubMed |
| 41009817 | Mesoporous Silicas of Well-Organized Structure: Synthesis, Characterization, and Investigation of Physical Processes Occurring in Confined Pore Spaces. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/41009817 | PubMed |
| 40978960 | Enhancing Drug Efficacy: A Review of Research Progress in Drug-Loaded Microspheres. | Cureus | 2025 | https://conductscience.org/library/papers/40978960 | PubMed |
| 40592481 | Tumor Membrane Based Delivery System Encapsulating Metfornin and TPP1 Peptide for Tumor Immune Therapy. | ACS Biomater Sci Eng | 2025 | https://conductscience.org/library/papers/40592481 | PubMed |
| 39624468 | Pioneering Advances and Innovative Applications of Mesoporous Carriers for Mitochondria-Targeted Therapeutics. | Br J Biomed Sci | 2024 | https://conductscience.org/library/papers/39624468 | PubMed |
| 39459653 | Regeneration and Single Stage Batch Adsorber Design for Efficient Basic Blue-41 Dye Removal by Porous Clay Heterostructures Prepared from Al13 Montmorillonite and Pillared Derivatives. | Materials (Basel) | 2024 | https://conductscience.org/library/papers/39459653 | PubMed |
| 38258085 | Functionalized Periodic Mesoporous Silica Nanoparticles for Inhibiting the Progression of Atherosclerosis by Targeting Low-Density Lipoprotein Cholesterol. | Pharmaceutics | 2024 | https://conductscience.org/library/papers/38258085 | PubMed |
| 38256959 | Recent Developments in Nanoparticle Formulations for Resveratrol Encapsulation as an Anticancer Agent. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/38256959 | PubMed |
| 38045216 | Enhanced electrocatalytic properties in dye-sensitized solar cell via Pt/SBA-15 composite with optimized Pt constituent. | Heliyon | 2023 | https://conductscience.org/library/papers/38045216 | PubMed |
| 38003350 | Toxicological Profiling and Long-Term Effects of Bare, PEGylated- and Galacto-Oligosaccharide-Functionalized Mesoporous Silica Nanoparticles. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/38003350 | PubMed |
| 37446768 | Hybrid Polymer-Silica Nanostructured Materials for Environmental Remediation. | Molecules | 2023 | https://conductscience.org/library/papers/37446768 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36903259
GET https://conductscience.org/api/papers/v1/36903259/references?page=2